The introduction of nicotinamide to be a nicotine substitute in e-cigarette and smokeless products represents a significant regulatory problem for that FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to work as a sedative at high dosages6. The claims produced by Nicotine River, ECBlend, as well as other distribut